Protalix Biotherapeutics Non-Current Deferred Revenue (Quarterly) Analysis

Protalix Biotherapeutics, Inc. (PLX)

2.08 +0.01 (+0.48%) USD | NYAM | Jan 12, 09:41

View Non-Current Deferred Revenue (Quarterly) for PLX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial